BNP Paribas Financial Markets’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-1,455
| Closed | -$38.7K | – | 3333 |
|
|
2015
Q4 | $38.7K | Sell |
1,455
-166
| -10% | -$4.42K | ﹤0.01% | 2981 |
|
|
2015
Q3 | $73.9K | Buy |
1,621
+994
| +159% | +$45.3K | ﹤0.01% | 2592 |
|
|
2015
Q2 | $20.2K | Buy |
627
+446
| +246% | +$14.4K | ﹤0.01% | 3051 |
|
|
2015
Q1 | $5.74K | Buy |
+181
| New | +$5.74K | ﹤0.01% | 3072 |
|
|
2014
Q4 | – | Sell |
-530
| Closed | -$14K | – | 3153 |
|
|
2014
Q3 | $14K | Buy |
530
+431
| +435% | +$11.4K | ﹤0.01% | 2918 |
|
|
2014
Q2 | $2.93K | Buy |
99
+80
| +421% | +$2.37K | ﹤0.01% | 2415 |
|
|
2014
Q1 | $621 | Sell |
19
-71
| -79% | -$2.32K | ﹤0.01% | 2546 |
|
|
2013
Q4 | $3.71K | Sell |
90
-1,553
| -95% | -$64.1K | ﹤0.01% | 2795 |
|
|
2013
Q3 | $87.1K | Sell |
1,643
-471
| -22% | -$25K | ﹤0.01% | 2114 |
|
|
2013
Q2 | $113K | Buy |
+2,114
| New | +$113K | ﹤0.01% | 2178 |
|